202 related articles for article (PubMed ID: 18336100)
21. Evaluation of C4d expression and staining patterns by immunohistochemistry in renal biopsy samples with focal segmental glomerulosclerosis and minimal change disease.
Abedi M; Nili F; Dehkhoda F; Abdollahi A; Salarvand S
Ann Diagn Pathol; 2024 Jun; 70():152281. PubMed ID: 38417352
[TBL] [Abstract][Full Text] [Related]
22. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[TBL] [Abstract][Full Text] [Related]
23. [Minimal change disease and focal segmental glomerulosclerosis in children--histomorphometric comparative study with application to computer image analysis].
Danilewicz M; Wagrowska-Danilewicz M
Przegl Lek; 1996; 53(7):529-33. PubMed ID: 8975287
[TBL] [Abstract][Full Text] [Related]
24. Podocyte mRNA in the urinary sediment of minimal change nephropathy and focal segmental glomerulosclerosis.
Szeto CC; Wang G; Chow KM; Lai FM; Ma TK; Kwan BC; Luk CC; Li PK
Clin Nephrol; 2015 Oct; 84(4):198-205. PubMed ID: 26308082
[TBL] [Abstract][Full Text] [Related]
25. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie.
Meyrier A; Noël LH; Auriche P; Callard P
Kidney Int; 1994 May; 45(5):1446-56. PubMed ID: 8072258
[TBL] [Abstract][Full Text] [Related]
26. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[TBL] [Abstract][Full Text] [Related]
27. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.
Siligato R; Cernaro V; Nardi C; De Gregorio F; Gembillo G; Costantino G; Conti G; Buemi M; Santoro D
Expert Opin Investig Drugs; 2018 Nov; 27(11):839-879. PubMed ID: 30360670
[TBL] [Abstract][Full Text] [Related]
28. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis.
Regele HM; Fillipovic E; Langer B; Poczewki H; Kraxberger I; Bittner RE; Kerjaschki D
J Am Soc Nephrol; 2000 Mar; 11(3):403-412. PubMed ID: 10703664
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
[TBL] [Abstract][Full Text] [Related]
30. [The clinic significance of urinary podocytes in patients with focal segmental glomerulosclerosis].
Li YH; Huang HC; Liu G; Zhang YK
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):135-8. PubMed ID: 15100729
[TBL] [Abstract][Full Text] [Related]
31. Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis.
An JN; Hyeon JS; Jung Y; Choi YW; Kim JH; Yang SH; Oh S; Kwon S; Lee SH; Cho JH; Park SH; Ha H; Kim DK; Lee JP; Hwang GS
Sci Rep; 2019 Oct; 9(1):14707. PubMed ID: 31605028
[TBL] [Abstract][Full Text] [Related]
32. [Minimal change disease and focal segmental glomerulosclerosis].
Müller-Deile J; Schenk H; Schiffer M
Internist (Berl); 2019 May; 60(5):450-457. PubMed ID: 30887070
[TBL] [Abstract][Full Text] [Related]
33. Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis.
Hansrivijit P; Cheungpasitporn W; Thongprayoon C; Ghahramani N
BMC Nephrol; 2020 Apr; 21(1):134. PubMed ID: 32293308
[TBL] [Abstract][Full Text] [Related]
34. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.
Tune BM; Mendoza SA
J Am Soc Nephrol; 1997 May; 8(5):824-32. PubMed ID: 9176855
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Cho MH; Hong EH; Lee TH; Ko CW
Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
[TBL] [Abstract][Full Text] [Related]
36. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986
[TBL] [Abstract][Full Text] [Related]
37. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
[TBL] [Abstract][Full Text] [Related]
38. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.
Pelletier JH; Kumar KR; Engen R; Bensimhon A; Varner JD; Rheault MN; Srivastava T; Straatmann C; Silva C; Davis TK; Wenderfer SE; Gibson K; Selewski D; Barcia J; Weng P; Licht C; Jawa N; Kallash M; Foreman JW; Wigfall DR; Chua AN; Chambers E; Hornik CP; Brewer ED; Nagaraj SK; Greenbaum LA; Gbadegesin RA
Pediatr Nephrol; 2018 Oct; 33(10):1773-1780. PubMed ID: 29982878
[TBL] [Abstract][Full Text] [Related]
39. Baseline characteristics and long-term outcomes of steroid-resistant nephrotic syndrome in children: impact of initial kidney histology.
Watanabe Y; Fujinaga S; Endo A; Endo S; Nakagawa M; Sakuraya K
Pediatr Nephrol; 2020 Dec; 35(12):2377-2381. PubMed ID: 32964318
[TBL] [Abstract][Full Text] [Related]
40. Urinary peptide profiling to differentiate between minimal change disease and focal segmental glomerulosclerosis.
Pérez V; Ibernón M; López D; Pastor MC; Navarro M; Navarro-Muñoz M; Bonet J; Romero R
PLoS One; 2014; 9(1):e87731. PubMed ID: 24498182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
